The Procter & Gamble Company (NYSE:PG) Shares Sold by Bath Savings Trust Co

Bath Savings Trust Co trimmed its position in The Procter & Gamble Company (NYSE:PG) by 1.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,974 shares of the company’s stock after selling 611 shares during the period. Bath Savings Trust Co’s holdings in Procter & Gamble were worth $7,205,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of PG. Concurrent Investment Advisors LLC boosted its position in Procter & Gamble by 4.5% during the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after acquiring an additional 4,035 shares during the last quarter. Copley Financial Group Inc. acquired a new stake in shares of Procter & Gamble during the third quarter worth $668,000. Fortem Financial Group LLC purchased a new stake in shares of Procter & Gamble in the fourth quarter valued at $569,000. Synovus Financial Corp lifted its position in Procter & Gamble by 3.4% during the third quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock worth $32,065,000 after buying an additional 6,077 shares during the period. Finally, Nordea Investment Management AB boosted its stake in Procter & Gamble by 7.5% in the 4th quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock worth $484,583,000 after buying an additional 201,695 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Wells Fargo & Company cut their price objective on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating on the stock in a report on Tuesday. Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a report on Monday, September 30th. Piper Sandler started coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price objective for the company. Evercore ISI lifted their target price on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Finally, JPMorgan Chase & Co. increased their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus target price of $179.75.

Insider Buying and Selling

In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the transaction, the insider now owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 75,439 shares of company stock valued at $13,317,460 in the last quarter. Company insiders own 0.18% of the company’s stock.

Procter & Gamble Stock Up 0.4 %

NYSE PG traded up $0.70 on Tuesday, hitting $161.30. 4,063,602 shares of the stock traded hands, compared to its average volume of 5,820,512. The stock has a 50-day moving average of $170.03 and a 200 day moving average of $169.80. The Procter & Gamble Company has a twelve month low of $146.28 and a twelve month high of $180.43. The company has a market capitalization of $379.87 billion, a P/E ratio of 27.81, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. Procter & Gamble’s revenue was down .6% on a year-over-year basis. During the same quarter last year, the company posted $1.83 earnings per share. As a group, analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.